Back to search
Myeloid Chimerism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myeloid Chimerism trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Myeloid Chimerism trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Previous studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be we…
Background: Sickle cell disease can often be treated with blood stem cell transplants. But for some people the disease returns. This study will give a second t…
AlloHeme is a blood-based monitoring test developed by the CareDx laboratory that utilizes NGS technology coupled with a proprietary algorithm to predict the li…
AlloHeme is a chimerism test service that utilizes NGS technology to analyze SNP loci to quantify donor and recipient cells by measuring genomic DNA. Before tra…